Short residence times in the bloodstream reduce the effectiveness of protein drugs. Application of an approach that combines protein and polymer engineering prolongs circulation time and increases drug uptake by tumours.
This is a preview of subscription content, log in via an institution to check access.
References
Leader, B., Baca, Q. J. & Golan, D. E. Nature Rev. Drug Discov. 7, 21–39 (2008).
Gao, W., Liu, W., Christensen, T., Zalutsky, M. R. & Chilkoti, A. Proc. Natl Acad. Sci. USA 107, 16432–16437 (2010).
Abuchowski, A., McCoy, J. R., Palczuk, N. C., van Es, T. & Davis, F. F. J. Biol. Chem. 252, 3582–3586 (1977).
Duncan, R. Nature Rev. Drug Discov. 2, 347–360 (2003).
Duncan, R. Nature Rev. Cancer 6, 688–701 (2006).
Veronese, F. M. & Pasut, G. Drug Discov. Today 10, 1451–1458 (2005).
Bailon, P. et al. Bioconj. Chem. 12, 195–202 (2001).
Gao, W. et al. Proc. Natl Acad. Sci. USA 106, 15231–15236 (2009).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hubbell, J. Longer-lived proteins. Nature 467, 1051–1052 (2010). https://doi.org/10.1038/4671051a
Published:
Issue Date:
DOI: https://doi.org/10.1038/4671051a
- Springer Nature Limited